Decision fatigue is a real thing. Every day there are a number of choices we need to make to ensure the success of both personal and career oriented endeavors. As publishers, a couple of top priorities include creating compelling content for your intended audiences and subsequently monetizing that content to produce and grow revenue.
The advertising technology industry has created an abundance of opportunity for revenue generation through the development of new advertising formats for direct sales efforts and third-party demand through supply-side platforms (SSPs). However, now more than ever there is an unprecedented number of SSPs, header bidders, header wrappers and more to choose from. Variety might be great when it comes to demand options, but not all varietal choices are created equally and choosing an SSP can be difficult. Below are a few recommendations to keep in mind to make the SSP evaluation process a little less cumbersome.
An SSP can never offer too much transparency. Accessing even the most granular data points will only help you make validated business decisions toward creating a lucrative monetization strategy. Always ask yourself how much visibility the vendor can and is willing to provide both now and in the future. The more, the better. Simple as that.
While it may seem as easy as working with multiple SSPs to maximize revenue, it’s not. The reality is that buyer quantity isn’t quite enough to justify the time and consideration it takes to grow a strong partnership with an SSP. As you continue evaluating vendors, thoughtfully consider the technology, control and level of transparency being offered. If those items add up, you’ll likely save yourself from additive decision fatigue and will definitely start seeing increased revenue growth.
For more information on Nativo’s unified ad server and supply-side platform, contact your Account Manager or reach out to us here.
Pharma advertisers are facing a fundamental challenge: justify value at every impression.
Read More
Part 2: Advertising in the Age of Accountability — Navigating Pharma’s New Media Mandate
Pharma’s future competitiveness won’t hinge solely on clinical data. It’ll depend on cultural relevance.
Read More
Part 1: From Science to Storytelling — Why Pharma’s Future Depends on Emotional Equity
Activate quickly and efficiently based on your goals and budget
Read More
Back to School, Better: Smart Advertising Strategies for 2025